November 13, 2006:
November 13, 2006: Nymox Pharmaceutical Corporation announced today its financial results for the third quarter of 2006.
November 3, 2006:
November 3, 2006: Nymox announced today that Dr. Paul Averback, CEO of Nymox Pharmaceutical, will present at the 29th Annual Westergaard SmallCap Conference on Monday, November 6, 2006.
October 31, 2006:
October 31, 2006: Nymox Pharmaceutical Corporation (NASDAQ: NYMX) announced today that the Company is in discussions with potential marketing partners for the Company’s NX-1207 drug for the treatment of benign prostatic hyperplasia (BPH), following the successful completion of a placebo-controlled, double-blind, multi-center Phase 2 trial.